These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27237210)

  • 1. Evaluation of serum uric acid levels in patients with oral squamous cell carcinoma.
    Ara SA; Ashraf S; Patil BM
    Indian J Dent Res; 2016; 27(2):178-83. PubMed ID: 27237210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Serum Uric Acid as a Protective Biomarker in Patients with Different Histopathological Grades of Oral Squamous Cell Carcinoma: a Case-Control Study.
    Manifar S; Rahimzamani A; Shirkhoda M; Ghamsari MN; Bakhshi M
    Biomed Res Int; 2020; 2020():5185423. PubMed ID: 33005687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum big endothelin-1 as a biomarker in oral squamous cell carcinoma patients: an analytical study.
    Mankapure PK; Barpande SR; Bhavthankar JD; Mandale M
    J Appl Oral Sci; 2015 Oct; 23(5):491-6. PubMed ID: 26537720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma.
    Rajkumar K; Ramya R; Nandhini G; Rajashree P; Ramesh Kumar A; Nirmala Anandan S
    Oral Dis; 2015 Jan; 21(1):90-6. PubMed ID: 24304502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative evaluation of serum fucose in oral squamous cell carcinoma patients.
    Parwani RN; Parwani SR
    J Cancer Res Ther; 2011; 7(2):143-7. PubMed ID: 21768700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of serum lactate dehydrogenase level in patients with oral premalignant lesions/conditions and oral squamous cell carcinoma: a clinicopathological study.
    Pereira T; Shetty S; Pereira S
    J Cancer Res Ther; 2015; 11(1):78-82. PubMed ID: 25879341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
    Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC
    J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Serum Gas6 Is a Novel Prognostic Biomarker in Patients with Oral Squamous Cell Carcinoma.
    Jiang T; Liu G; Wang L; Liu H
    PLoS One; 2015; 10(7):e0133940. PubMed ID: 26207647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipid profile in oral squamous cell carcinoma: alterations and association with some clinicopathological parameters and tobacco use.
    Acharya S; Rai P; Hallikeri K; Anehosur V; Kale J
    Int J Oral Maxillofac Surg; 2016 Jun; 45(6):713-20. PubMed ID: 26899131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum placenta growth factor level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
    Cheng SJ; Lee JJ; Cheng SL; Chen HM; Chang HH; Wang YP; Kok SH; Kuo MY; Chiang CP
    Oral Oncol; 2012 May; 48(5):424-8. PubMed ID: 22244591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Serum Fucose Levels in Leukoplakia and Oral Cancer Patients.
    Rai NP; Anekar J; Shivaraja Shankara YM; Divakar DD; Al Kheraif AA; Ramakrishnaiah R; Sebastian R; Raj AC; Al-Hazmi A; Mustafa SM
    Asian Pac J Cancer Prev; 2015; 16(17):7497-500. PubMed ID: 26625751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of 25-hydroxy-vitamin D in patients with oral squamous cell carcinoma: Making a case for chemoprevention.
    Udeabor SE; Albejadi AM; Al-Shehri WAK; Onwuka CI; Al-Fathani SY; Al Nazeh AA; Aldhahri SF; Alshahrani FA
    Clin Exp Dent Res; 2020 Aug; 6(4):428-432. PubMed ID: 32246747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Annexin A2 Level Is Associated With Diagnosis and Prognosis in Patients With Oral Squamous Cell Carcinoma.
    Zhang W; Gao C; Zhang S; Fang G
    J Oral Maxillofac Surg; 2017 May; 75(5):1081-1087. PubMed ID: 27889534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of serum ferritin level in potentially malignant disorders, oral squamous cell carcinoma, and treated cases of oral squamous cell carcinoma.
    Khanna V; Karjodkar F; Robbins S; Behl M; Arya S; Tripathi A
    J Cancer Res Ther; 2017; 13(3):550-555. PubMed ID: 28862225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trace elements (copper, zinc, selenium and molybdenum) as markers in oral sub mucous fibrosis and oral squamous cell carcinoma.
    Khanna S; Udas AC; Kumar GK; Suvarna S; Karjodkar FR
    J Trace Elem Med Biol; 2013 Oct; 27(4):307-11. PubMed ID: 23664922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of glutathione S-transferase pi correlates with poorly differentiated grade in patients with oral squamous cell carcinoma.
    Ma HL; Yu C; Liu Y; Tan YR; Qiao JK; Yang X; Wang LZ; Li J; Chen Q; Chen FX; Zhang ZY; Zhong LP
    J Oral Pathol Med; 2015 Mar; 44(3):193-200. PubMed ID: 25047743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum soluble CD44v6 levels in patients with oral and maxillofacial malignancy.
    Chang SM; Xing RD; Zhang FM; Duan YQ
    Oral Dis; 2009 Nov; 15(8):570-2. PubMed ID: 19563418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of pretreatment serum interleukin-6 and tumour necrosis factor alpha as a potential biomarker for recurrence in patients with oral squamous cell carcinoma.
    Skrinjar I; Brailo V; Vidovic-Juras D; Vucicevic-Boras V; Milenovic A
    Med Oral Patol Oral Cir Bucal; 2015 Jul; 20(4):e402-7. PubMed ID: 25858079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma.
    Yang CZ; Ma J; Luo QQ; Neskey DM; Zhu DW; Liu Y; Myers JN; Zhang CP; Zhang ZY; Zhong LP
    J Oral Pathol Med; 2014 Jan; 43(1):28-34. PubMed ID: 23710769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GDF 15 as an anti-apoptotic, diagnostic and prognostic marker in oral squamous cell carcinoma.
    Schiegnitz E; Kämmerer PW; Koch FP; Krüger M; Berres M; Al-Nawas B
    Oral Oncol; 2012 Jul; 48(7):608-14. PubMed ID: 22341306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.